Pursglove Geordan Garrett 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jul 9, 2025
Insider Transaction Report
Form 4
Pursglove Geordan Garrett
DirectorCEO and Chairman of the Board
Transactions
- Award
Options to Purchase Common Stock
2025-07-03+350,000→ 350,000 totalExercise: $2.83From: 2025-07-03Exp: 2030-07-03→ Common (350,000 underlying)
Footnotes (1)
- [F1]Effective July 3, 2025, the reporting person was granted stock options to purchase an aggregate of 350,000 shares vesting 50% on the effective date, 25% on September 30,2025 and 25% on December 31,2025. The grant was a signing bonus for the reporting person entering into an employment agreement with the issuer. The exercise price is $2.83 per share.